Drug Delivery Investigation of Trans-Ferulic Acid Loaded Proniosomal Gels
ACS Omega · 18.08.2026 · 11 (32) · 47459-47472
DOI: 10.1021/acsomega.6c01402 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Omega, online erschienen am 03.08.2026. Verfasst von Marwa Saady und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, School of Sciences & Engineering, The American University in Cairo, AUC Avenue, P.O. Box 74, New Cairo 11835, Egypt. Die Arbeit nennt 107 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: American University in Cairo.
Abstract (Originalsprache)
Background
Proniosomes are anhydrous, free-flowing formulations that, upon hydration, yield niosomes-lipid-based vesicles. These biocompatible vesicles represent a promising vehicle for drug delivery in melanoma treatment.
Methods
This study aimed to develop a melanoma therapy by combining the benefits of proniosomes with the reported anticancer activity of the natural phenolic compound Trans-ferulic acid (T-FA). Six formulations of T-FA-loaded-proniosomes (PrN-1 to PrN-6) were prepared and compared in terms of their physicochemical parameters, entrapment efficiency, and antioxidant activity. Additionally, cytotoxicity against melonoma cells and skin permeability of the proniosome-loaded-T-FA formulations were studied.
Results
The optimized T-FA niosomal dispersions showed a %EE of 69.01%, zeta potential of 37.6 mV, PDI of 0.237, %TLC of 34.51%, and nanosized particles. The hydrated niosomal dispersions preserved the scavenging capacity of T-FA (SC50 of 11.34–12.17 μg/mL). The T-FA- niosomal dispersions for PrN-1 (IC50 of 171.75 μg/mL) and PrN-5 (IC50 of 41.58 μg/mL) exhibited greater cytotoxicity on the A-375 melanoma cell line compared to free T-FA (IC50 of 275.06 μg/mL). The in vitro release study showed a pH-sensitive and diffusion-based sustained release behavior. The permeability of T-FA from the proniosomal gel displayed optimum permeability coefficient and T-FA flux; PrN-2 (0.00379 ± 0.0006 cm/h and 7.586 ± 0.11 μg/cm2 h–1) and PrN-5 (0.00434 ± 0.001 cm/h and 8.69 ± 0.13 μg/cm2 h–1).
Conclusion
The prepared proniosomal gels efficiently encapsulated T-FA, maintained its antioxidant properties, and enhanced its cytotoxic effects against A-375 melanoma cells.
Autor:innen und Institutionen
- Department of Chemistry, School of Sciences & Engineering, The American University in Cairo, AUC Avenue, P.O. Box 74, New Cairo 11835, Egypt.
ORCID-Profile: Marwa Saady, Hassan Mohamed El-Said Azzazy
Förderung
- American University in Cairo
Zitieren
APA
Saady, M., Maher, A., & Azzazy, H. M. E. (2026). Drug Delivery Investigation of Trans-Ferulic Acid Loaded Proniosomal Gels. ACS Omega, 11(32), 47459-47472. https://doi.org/10.1021/acsomega.6c01402
Vancouver
Saady M, Maher A, Azzazy HME. Drug Delivery Investigation of Trans-Ferulic Acid Loaded Proniosomal Gels. ACS Omega. 2026;11(32):47459-47472. doi:10.1021/acsomega.6c01402
BibTeX
@article{Saady2026,
author = {Saady, Marwa and Maher, Ahmed and Azzazy, Hassan Mohamed El-Said},
title = {Drug Delivery Investigation of Trans-Ferulic Acid Loaded Proniosomal Gels},
journal = {ACS Omega},
year = {2026},
volume = {11},
number = {32},
pages = {47459--47472},
doi = {10.1021/acsomega.6c01402}
}
EUVIMED